Keros Therapeutics, Inc. - Common Stock (KROS)

CUSIP: 492327101

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-1,605,548
Put/Call ratio
232%
SEC-reported price per share
$11.04
Number of holders
148
Value change
-$29,235,035
Number of buys
68
Open additional details 1 more signal available
Number of sells
93
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
19,896,940

Security key

492327101

Report period

Q1 2026

Institutions

148

Top holders

10

Ownership snapshot

Top reported holders of KROS - Keros Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 6.9% 13D/G row: Nantahala Capital Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Nantahala Capital Management, LLC leads the comparable SEC ownership view at 6.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Nantahala Capital Management, LLC 6.9%
D. E. SHAW & CO, L.P. 3.9%
Madison Avenue Partners, LP 2.7%
ALKEON CAPITAL MANAGEMENT LLC 2.7%
FMR LLC 1.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nantahala Capital Management, LLC
13D/G 13F
Company
6.9%
$17,073,258
1,360,419 shares
$0 31 Mar 2026
D. E. SHAW & CO, L.P.
13D/G
3.9%
$14,745,042
756,156 shares
-$15,400,944 31 Dec 2025
Madison Avenue Partners, LP
13F 13D/G
Company · Madison Avenue International LP
2.7%
from 13D/G
$16,770,675
823,707 shares
31 Dec 2025
ALKEON CAPITAL MANAGEMENT LLC
13D/G
2.7%
$15,645,210
1,101,000 shares
$0 31 Dec 2024
FMR LLC
13D/G 13F
Company
1.7%
$10,010,547
704,472 shares
$0 31 Jan 2025
JPMORGAN CHASE & CO
13D/G
0.2%
$1,617,141
113,803 shares
-$35,146,204 30 Apr 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
148
Shares
18,564,379
Rows available
148
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
148
Q1 2026 holders
148
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .